- Home
- SOFI vs ONC Comparison
SOFI vs ONC Comparison
Compare SOFI & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOFI | ONC |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | 12000 |
| Industry | Diversified Financial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.4B | 33.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SOFI | ONC |
|---|---|---|
| Price | $17.72 | $287.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | $26.18 | ★ $386.70 |
| AVG Volume (30 Days) | ★ 54.1M | 226.6K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $619,353,000.00 | N/A |
| Revenue This Year | $33.02 | $759.19 |
| Revenue Next Year | $22.93 | $14.51 |
| P/E Ratio | ★ $47.44 | $614.06 |
| Revenue Growth | ★ 23.10 | N/A |
| 52 Week Low | $8.62 | $196.53 |
| 52 Week High | $32.73 | $385.22 |
Technical Indicators
Market Signals| Indicator | SOFI | ONC |
|---|---|---|
| Relative Strength Index (RSI) | 33.71 | 30.45 |
| Support Level | $17.09 | $234.09 |
| Resistance Level | $19.48 | $306.61 |
| Average True Range (ATR) | 0.87 | 9.32 |
| MACD | 0.17 | -4.40 |
| Stochastic Oscillator | 24.24 | 3.07 |
Price Performance
Historical ComparisonAbout SOFI SoFi Technologies Inc.
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
About ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.